'The long-term bounceback will be strong'

--  |   17/03/2020 Text size  Decrease  Increase   |  
email_fwd
<p><strong>Lex Hall: </strong>Hi, I'm Lex Hall, content editor with Morningstar Australia. I thought today I'd catch up with the director of equity research, Johannes Faul, to talk about the plunging markets, what it means, what the outlook holds and also, to look at some stocks that are in buying territory.</p> <p>Johannes, thanks for your time today.</p> <p><strong>Johannes Faul: </strong>Thanks for having me, Lex.</p> <p><strong>Hall: </strong>Now, someone yesterday, I think, said this is the correction we had to have. Markets have plunged to levels not seen since 1987. Is this the correction we had to have, do you think, do you agree?</p> <p><strong>Faul: </strong>Oh, as in the decline we have seen, sharp declines&hellip;</p> <p><strong>Hall: </strong>Yeah.</p> <p><strong>Faul: </strong>&hellip;since 1987, I think the markets are still a bit higher, thankfully. But look, you know, that that point on the correction, if we look back a couple of months, at Morningstar, we were seeing the markets overvalued on average. So, if you took our average coverage in Australia and weighted that by the market cap, we were saying, hey, the market is 20 per cent overvalued.</p> <p><strong>Hall: </strong>Yeah.</p> <p><strong>Faul: </strong>There's a lot of downside risk here. The one takeaway, though, is that in our view, the sale is overdone, and we see a lot of opportunities emerging actually for investors in the Australian market to take an opportunity here and buy some shares.</p> <p><strong>Hall: </strong>Yeah. Well, as we said today, I think, there&rsquo;s a stock list here of about 50 stocks or so that are 5-Star currently, so there are buying opportunities out there. We'll talk about that in a sec. What do you think the short-term outlook is for Australia, and the long term? What's the short term?</p> <p><strong>Faul: </strong>Yeah. Look, I mean, Morningstar's healthcare strategist in the US, Karen Andersen, came out with a very interesting piece. And what she's done, she's done a very deep-dive analysis on how have previous pandemics played out. And based on those figures, plus the outlook, that we'll have a treatment most likely by the end of this year, maybe even autumn, the northern hemisphere autumn, coming up. So, this will be a short-term issue, the health issue. Obviously, there's other repercussions, secondary knock-on effects and people are perhaps rightly so worried about the financial system. But what we've seen from the central banks and politicians globally is a lot of monetary easing, a lot of fiscal stimulus already coming through and they've acted very quickly, which really abates that risk. So, when we think about the global impact, it's going to be material. It has already been material. The Chinese numbers came out overnight, and how far their economy is slowing. We've talked about that, and what that means for Australia. But the short-term impact is going to be material; but long term, we think this is going to go away and actually with all this stimulus, with all this easing happening, we see the bounce back will be quite strong.</p> <p><strong>Hall: </strong>OK. Yeah, after SARS, for example, it took about six months and then we saw a rebound. So, hopefully, we'll see something like that. And as you say, we're already seeing this morning, Tuesday morning, we're seeing a slight bump. BHP is up 8 per cent, for example.</p> <p><strong>Faul: </strong>Yes.</p> <p><strong>Hall: </strong>You were saying that is linked to China and&hellip;</p> <p><strong>Faul: </strong>Perhaps, perhaps and look, markets are still very volatile. And it reminds me of a decade ago when large indices, like the S&amp;P 500, were whipping around quite a bit. We're talking 5 per cent moves overnight, up or down. And it just &ndash; all this volatility to me &ndash; suggests a lot of people are in the dark a bit, like, &lsquo;What does this mean? How severe is going to be the impact?&rsquo; We looked at a few studies from the mid-90s, which gave different ranges of short-term GDP growth impacts of pandemics and they range, obviously, between, low &ndash; very low single digits up to 10 per cent. In our mind, in our weighted case, we think that GDP growth this year will be slammed by 2 percentage points.</p> <p><strong>Hall: </strong>OK.</p> <p><strong>Faul: </strong>To put that in perspective, the IMF thought earlier this year, in January, GDP growth would be 3.3 per cent. So, we're taking a bit sliver off that. We're not thinking there's going to be a global recession at this stage.</p> <p><strong>Hall: </strong>OK. Let's turn to buying opportunities and stock picking. Like I said, we've got a list here of 50 stocks that are in 5-Star territory.</p> <p><strong>Faul: </strong>Yes.</p> <p><strong>Hall: </strong>Are they all buys? And you were mentioning earlier that it's very important to take into account companies&rsquo; balance sheet. Like consumers, like retail investors, they have debts and bills that they've got to pay, and that's the big problem for small businesses in the short term. Some of them won't survive. Tell us about evaluating 5-Star stocks and looking at the balance sheet.</p> <p><strong>Faul: </strong>Yeah. So, I think that that's a very valid question what you say and I think it really needs to be looked at on a case-by-case study, or just by case by case, in terms of: how do these companies balance sheets actually look? Are they strong enough to withstand three months of this, six months of this, 12 months of this weakness? We obviously don't know how long is our economy going to slow for. But look, we're seeing, we're seeing China coming back. They're returning to work. Their workers are returning to the offices, their workers are returning to the factories. And it's been a couple of months. It will take some time to revamp everything.</p> <p><strong>Hall: </strong>Yeah.</p> <p><strong>Faul: </strong>But if you think about the capabilities, the capacity of the economy itself, that hasn't been touched by the coronavirus. It hasn't destroyed any machinery or such in that sense. So, we think&hellip;</p> <p><strong>Hall: </strong>People have just stopped, activities have stopped.</p> <p><strong>Faul: </strong>Exactly. We've just ground to a halt. And it's been an abrupt one, too. Again, some sectors, some industries are hit harder than others.</p> <p><strong>Hall: </strong>Yeah.</p> <p><strong>Faul: </strong>And we can talk about supermarkets versus airlines for instance.</p> <p><strong>Hall: </strong>Yeah.</p> <p><strong>Faul: </strong>But we think that it will be short term, that demand will bounce back. And again, circling back to our house view is, yes, a severe near-term impact on GDP, but longer term I think there's going to be strong bounce with above trend GDP growth, over three years, as we bounce. And then, long term in terms of total global output, we think we're only going to be a bit of a sliver lower in 2024 than we would have been without corona only by 0.3 per cent.</p> <p><strong>Hall: </strong>All right. So, Johannes, overall, you see a vaccine. Our research suggests a vaccine within a year-and-a-half perhaps and world GDP to recover.</p> <p><strong>Faul: </strong>Yes, absolutely. So, our research suggests there could be a treatment out early, so by the end of 2020. There could be a vaccine by mid to late 2021, that's our view. And hence, once corona is gone, and we can manage it, we think the economy is going to bounce back, and bounce back strongly. So, again, it's just a short-term impact, in our view.</p> <p><strong>Hall: </strong>All right. Well, you're in the middle of preparing a report, which will be out later this week, and we look forward to reading that. So, thanks for your insights.</p> <p><strong>Faul: </strong>Absolutely. Thank you, Lex.</p> <p><strong>Hall: </strong>I'm Lex Hall for Morningstar. Thanks for watching.</p>

Video Archive...

3 undervalued names in childcare
05/08/2020  Morningstar's Gareth James identifies three sector names trading at attractive discounts in an increasingly 'essential' sector.
Is the 60/40 portfolio dead?
05/08/2020  Reports of the strategy's demise are greatly exaggerated, says Morningstar's Christine Benz.
Why you should ignore a fund's yield
04/08/2020  Investors may assume a fund's yield to determine how much income it will pay, but it's not always so simple, warns Morningstar analyst Rajesh Yadav.
What are the right bonds for retirees today?
03/08/2020  It depends on your expectations and timeframe. Look at bonds as being portfolio stabilisers—sources of cash flow you can draw on when your equities are down, says Christine Benz.
3 top picks in rail, roads and utilities
28/07/2020  When utility stocks plunged during the onset of the pandemic Lazard Asset Management's Warryn Robertson knew it was time to jump in.
Infrastructure stocks in the covid era
24/07/2020  Lazard Asset Management's Warryn Robertson looks at how the pandemic has affected toll roads and airports and what the future of travel holds.
ESG stocks shine in covid-19 crisis
23/07/2020  Morningstar analyst Tancrede Fulop singles out a few companies that have performed well and also led the way in looking after staff. 
Stock-picking: Have you got what it takes?
21/07/2020  New stock-pickers are prone to lose money. Are the lessons worth the price? We ask Morningstar's Christine Benz.
Why mining stocks aren't yield plays
20/07/2020  Elevated iron ore prices have lifted mining company earnings to eye-watering levels but this doesn't make them income stocks, says Morningstar's Mat Hodge.
Commodity stocks riding high, but for how long?
17/07/2020  Local miners should deliver stellar fiscal 2020 results but such outperformance is unlikely to last, says Morningstar’s Mat Hodge.
The rise and rise of Amazon
17/07/2020  --
Should your portfolio shift when the economy slumps?
16/07/2020  How to make some upgrades during this down time.
Will Airbnb IPO or what?
16/07/2020  Covid-19 has made the intended public offering impossible, says Morningstar's Andrew Willis.
3 Japanese stock picks
15/07/2020  JPMorgan's Nicholas Weindling talks opportunities in Japan and reveals the stock that has been his largest holding for almost a decade
Small cap stocks: 'Inevitably, we see it all end in tears'
15/07/2020  The asset class has a habit of outperforming but Morningstar's Ross MacMillan sees signs of a bubble.
A trio of growth stocks
13/07/2020  Rachel Winter of UK fund manager Killik & Co talks payments, social media and investing in her monthly stock pick round-up
3 reasons healthcare is showing fit performance
09/07/2020  And what we expect to see moving forward.
Same old story: growth beats value
07/07/2020  Large growth maintains its supremacy in the Morningstar Style Box during a volatile first half for mutual funds. 
Nikko's 3 top Asian picks
06/07/2020  Nikko Asset Management's Peter Monson looks for strong sustainable returns and he sees that in Asian stocks that span financial exchanges, computer game makers and condiments suppliers.
How appealing are Asian stocks?
02/07/2020  China’s ongoing recovery from COVID-19 presents solid investment opportunities, says Nikko Asset Management.
'Unemployment will be higher, activity lower'
01/07/2020  Aviva Investors' Mark Robertson on the 'second wave', the widening gap between the West and China, portfolio protection and how covid has accelerated the tech revolution.
Smartwatches and luxury watches battle for your wrist
29/06/2020  Does the rise in smartwatches show that data, not diamonds, are a girl's best friend?
3 top picks in water and waste
26/06/2020  They may be 'boring' says Fidelity's Bertrand Lecourt but these names offer solid and long-term returns by delivering essential services.
Tapping opportunities in water and waste
25/06/2020  The growing consumption of water and the increased production of waste make these sectors compelling investments, says Fidelity's Bertrand Lecourt.
Dividends: ‘You have to be very active in stock selection’
23/06/2020  Yield can still be found among global healthcare, technology and consumer staples despite the dismal dividend outlook, says Janus Henderson’s Jane Shoemake.
Airlie went shopping during COVID sell-off
22/06/2020  COVID has given consumers the "fright of their lives" but this fund manager took the opportunity to scoop up bargain bluechips, says portfolio manager Matt Williams.
3 top picks: miner, insurer, fueler
19/06/2020  Mineral Resources, Medibank Private and Ampol are among Airlie Fund Management's preferred stocks, says portfolio manager Matt Williams.
Retail bonanza can’t last, warns Morningstar
16/06/2020  Investors shouldn’t project the pandemic-driven performance of JB HiFi and Harvey Norman too far into the future.
3 Aussie equities to watch
11/06/2020  Lazard Asset Management's Philipp Hofflin explains why mortgage processing, insurance and aluminium production are on his radar.
Are value stocks due for a comeback?
10/06/2020  Value investing has massively underperformed growth over the past decade. Christine Benz talks with Alex Bryan about the fundamental case for value.
3 top picks for a covid crisis
05/06/2020  Specialist consulting firms and chocolate bars. It's a disparate mix but Ned Bell of Bell Asset Management has good reason for seeing value in these sectors right now.
What the share market is missing
04/06/2020  Earnings results will be a rude awakening, says Ned Bell of Bell Asset Management, but there is nevertheless value among some global small- to mid-cap stocks.
The dividend balancing act
03/06/2020  Ensure your dividend-paying companies are more than attractive on the surface with these tips from Morningstar Canada's director of investment research, Ian Tam, CFA.
How dividend-paying stocks fit into retiree portfolios
01/06/2020  Christine Benz suggests retirees should take a balanced approach to these strategies.
Casino comeback and the uncertainty engulfing Seven West
29/05/2020  Most punters would prefer to lose money with their friends in a real casino than gambling online alone in their basement, says Brian Han.
The WFH reality-check for REITs
28/05/2020  Working from home means upheaval for office landlords but shopping mall owners are enjoying the end of hibernation, says Morningstar's Brian Han.
An undervalued, wide-moat name in healthcare
27/05/2020  Companies racing for a coronavirus cure have moved to lofty valuations. Morningstar analyst Alex Morozov is looking for lesser-known healthcare names.
5 investing mistakes to avoid
20/05/2020  Christine Benz discusses pitfalls investors encounter as they navigate volatility and recovery.
Ugly housing outlook won’t last
19/05/2020  Adelaide Brighton, Amcor and Bingo should ride out the housing construction slump with relative ease, says Morningstar’s Grant Slade. 
3 stocks set to clean up
18/05/2020  The biggest corporate hygiene company you never heard of; Dettol's parent company; and a lab supplier are tipped to benefit post-coronavirus.
Greencape's three top picks
13/05/2020  Property listings, software for financial planners and AI machine-learning: Jonathan Koh has scoured the globe for opportunities.
Where to hunt when guidance statements get torn up
12/05/2020  Greencape Capital entered the downturn with a cash reserve that has allowed it to snare some essential services companies at bargain prices, says Jonathan Koh.
Investing basics: the hardest decision in investing
08/05/2020  When and how should you get back into equity markets after panic selling?
Weighing up Australia’s banks
07/05/2020  Bad debts and expected capital raising from three of the big four cloud the outlook for Aussie banks, says Morningstar's Nathan Zaia.
Surprises from Berkshire's annual meeting
05/05/2020  Morningstar's Gregg Warren discusses the meeting's cautious tone, Berkshire's lack of buying during the downturn, and unloading the airlines.
Banks will see out corona crisis
04/05/2020  Loan defaults, shaky house prices and a dividend pause - it's ugly in the short term but Nathan Zaia has long-term faith in Australia's banks.
What the pandemic means for Berkshire Hathaway
30/04/2020  Gregg Warren shares his thoughts on its valuation and more.
Netflix steals the show but for how long?
29/04/2020  What happens when the lockdown ends? The streaming giant may need to get some serious growth in international markets to make up for investor expectations. 
Unique, but normal: riding out this market crisis
27/04/2020  The markets follow patterns. We discuss ways to find your way to the upside of the current environment.
3 defensive utility stocks
23/04/2020  These utility stocks aren't the cheapest but have solid balance sheets and decent yield potential.
What in the world happened to oil prices?
22/04/2020  Amid such a painful downturn and the ensuing demand shock, it's crucial to consider companies that are in sound financial health, says Dave Meats.
'An apocalyptic asset': owning gold
21/04/2020  Gold can be a useful insurance policy for investment portfolios, says Morningstar analyst Kenneth Lamont, but it's not perfect
Energy crisis will be short-lived
20/04/2020  Will energy majors bounce back from the coronavirus-induced turmoil? You bet they will, says Mark Taylor and here are the names to watch.
What role do bonds play in an era of ultralow yields?
16/04/2020  Investors are right to be questioning bonds' role in their portfolios, but they still serve a useful purpose for many.
US tech sector now decently undervalued
14/04/2020  We examine how this sector handled the market turmoil and what to expect
Will energy stocks rise from the ashes?
09/04/2020  Investors' current concerns are justified, but vast long-term opportunities remain in this significantly undervalued sector.
Corona crisis threatens big four dividends
08/04/2020  The short-term may be scary but the major banks' long-term outlook will withstand the shock, says Morningstar's Nathan Zaia.
What to expect as the virus continues
08/04/2020  Christine Benz and Karen Andersen discuss Morningstar's latest views on stopping the spread of the virus as well as the economic implications.
In volatile markets, it's OK to chicken out
03/04/2020  Christine Benz explains why now isn't the time for grand gestures with your investments; instead, take a light touch to them.
Avoiding all eggs in the same basket
02/04/2020  Get the full effect of diversification by considering the correlation of your assets with these tips from Morningstar's Director of Investment Research, Ian Tam
Coronavirus: stock up on quality companies
01/04/2020  Retail and energy companies rank among Morningstar's sector picks, despite seeing some of the sharpest falls since coronavirus hit.
Is this 2008 all over again?
31/03/2020  Eric Jacobson explains why the banking system is not at the centre of the corona crisis, and in fact, is well positioned to be a tool to help solve it.
The critical reason to stay invested
30/03/2020  Why it's important to stay invested to capture critical months for your portfolio, with Morningstar's director of investment research, Ian Tam
How to avoid dividend cuts
27/03/2020  A wave of companies are expected to cut their dividends amid the coronavirus crisis. Morningstar's Dan Lefkovitz explains how to spot a firm that could its pay out.
Healthcare stocks still defensive, says Morningstar
26/03/2020  Respiratory specialist Fisher & Paykel Healthcare is among stocks now enticingly priced as the coronavirus hits markets and the Aussie dollar.
Cheap or nasty? Seven, Nine and Telstra
24/03/2020  A stock that’s heavily sold down isn’t always a screaming buy, as proven by this comparison of debt and other fundamentals among these well-loved companies.
Mining stocks offer price opportunity, dividend threat
20/03/2020  OZ Minerals, South32 and Iluka are among miners dipping into buy territory amid the coronavirus selloff but dividends are at risk, says Morningstar’s Mat Hodge.
Market, economic implications amid latest virus news
20/03/2020  Karen Andersen and Preston Caldwell give us their latest perspectives on healthcare and energy.
'The long-term bounceback will be strong'
17/03/2020  The coronavirus fallout is hurting but there should be a treatment by year end and the rebound will be strong, says Morningstar director of equities Johannes Faul. 
Taking control in time of corona
17/03/2020  In this timely Morningstar panel discussion, but Christine Benz and Andrew Lill provide  concrete tips on how curb your losses and put your money to use.
The importance of staying invested in volatile times
16/03/2020  Don't flee the market in a panic, but rather embrace the turmoil as an investment opportunity—you'll be better off in the long run.
‘A modest sell-off, not a panic’: Douglass on coronavirus fallout
14/03/2020  The Magellan co-founder insists now is not the time to ditch stocks for cash nor to buy bargains, and global businesses won’t turn their backs on China.
Avoid panic-selling: Douglass calls for calm
12/03/2020  Share market speculation is almost always a bad idea, and panic-selling stocks on coronavirus fears is an example of just that, warns Magellan boss.
Coronavirus and the market: our take
11/03/2020  We offer three takeaways and advice on staying true to your goals.
Hits and misses aplenty in first half 2020 - Part 2
10/03/2020  Consumer stock Breville and listed property firm Charter Hall were among the highest gainers after delivering results, while Mayne Pharma and Seven West saw the sharpest falls.
Hits and misses aplenty in first half 2020 - Part 1
09/03/2020  The interim reporting season served up a lesson in why investors shouldn't rely too heavily on company forecasts, says Morningstar's Peter Warnes
The best diversifiers for your equity portfolio
05/03/2020  Christine Benz discusses how to protect your portfolio from a stock-market sell-off.
Green bonds offer another side to ESG investing
05/03/2020  Investors are largely unaware of the role fixed income can play in expressing their views on social, environmental and governance issues.
ETF investing for the new decade: 4 trends to watch
02/03/2020  In only a decade, the value of Australia's ETF market has risen by almost 2000 per cent.
The new medical device company to watch
28/02/2020  Spray-on skin maker Avita Medical has a chance of becoming the new standard in burns treatment, says Morningstar's Nicolette Quinn. 
Helping financial advisers help investors
27/02/2020  Financial advice can deliver value but we must do a better job of showing what that is and measuring it, says Morningstar chief executive Kunal Kapoor.
'ESG is about building a portfolio for outperformance'
26/02/2020  Morningstar CEO Kunal Kapoor explains the importance of ESG investing and why it's not simply a matter of avoiding guns, smokes and booze.
Volatility is here to stay - here's what to do
25/02/2020  Morningstar's director of personal finance Christine Benz explains how investors - young and old - should navigate how the coronavirus, the US election and frothy stock prices.
Why mining dividends are a flash in the pan
24/02/2020  A near-record dividend payout from BHP reflects high iron ore prices and miners flush with cash, but these conditions won’t continue long-term, says Morningstar’s Mat Hodge.
The case for emerging market debt
20/02/2020  Lazard Asset Management's Arif Joshi demystifies emerging market debt and explains why it can offer excess yields.
Telstra faces Vodafone-TPG tie-up
18/02/2020  Morningstar equity analyst Brian Han reckons the Vodafone-TPG is a 75pc chance of proceeding but says there's a risk of overestimating its effect on Telstra.
CBA result puts dividend fears to bed, NAB on track
14/02/2020  Despite a profit dip there are many positives for CBA, including growth in mortgages and deposits and a strong balance sheet, says Morningstar equity analyst Nathan Zaia.
Doubts over James Hardie's bullish outlook
14/02/2020  The building materials supplier's long-term North American market share forecast is too ambitious, says Grant Slade 
Could Coronavirus hit China's luxury boom?
12/02/2020  Morningstar analyst Jelena Sokolova looks at the potential impact of the coronavirus on the luxury goods sector.
4 healthcare stocks attractive on valuation and ESG risk
10/02/2020  Morningstar's Karen Andersen explains how environmental, social and governance issues affect Big Pharma and biotech companies.
Coal case: why Whitehaven is a Best Idea
07/02/2020  Lower costs, higher prices, and demand from Asia: key reasons why the miner's shares are going cheap, says Morningstar director of equity research Mathew Hodge.
Two of Morningstar's Best Ideas
04/02/2020  Morningstar's Adam Fleck explains how his team decides on which names to recommend and reveals a stock that is trading at a 30 per cent discount to its fair value estimate.
Behind Morningstar's Global Best Ideas list
03/02/2020  A margin of safety and high analyst conviction are just two of the criteria behind this monthly selection of stocks for your watchlist, says Morningstar's Adam Fleck.
Morningstar's tribute to Jack Bogle
29/01/2020  There has never been anyone who has given more to investors and taken less in return than Jack Bogle.
Kraft Heinz on the comeback trail
23/01/2020  As the faltering firm works toward a turnaround, patient investors should consider its undervalued shares.
3 foodie stock picks
21/01/2020  Sarasin's Jeneiv Shah looks at three stocks across the food chain, including one company trying to stop cows from burping.
Morningstar's predictions for 2020
16/01/2020  A contraction in housing starts; advances in electric vehicle technology; Trump re-election; a rate cut; and another tough year for banks - just some of what's expected.
3 European stock picks for 2020
14/01/2020  Unloved cable companies and property firms provide some of the best opportunities in Europe, says T. Rowe Price's Dean Tenerelli. 
Best of 2019: Why Iluka is bucking the mining company trend
09/01/2020  In May 2019, Morningstar's Mat Hodge explained why this rare earths company provides a different exposure to consumer materials, and has a clear path to revenue growth.
Best of 2019: how to pick stocks like Warren Buffett
08/01/2020  In this Best of 2019 video, Morningstar director of investor education Karen Wallace reveals how Warren Buffet benefited from sniffing out companies with competitive advantages.